Calumet, Inc - Common Stock (CLMT)
12.98
0.00 (0.00%)
Calumet Inc is a diversified specialty petroleum and petrochemical company that primarily focuses on producing and marketing a wide range of high-quality performance products
The company operates various refineries and facilities, allowing it to create products such as lubricants, waxes, and solvents, which cater to different industries including automotive, agricultural, and personal care. In addition to its manufacturing capabilities, Calumet also engages in the storage and transportation of petroleum products, supporting its extensive distribution network. With a commitment to sustainability and innovation, Calumet aims to provide effective solutions and enhance performance for its customers through its unique product offerings.
Previous Close | 12.98 |
---|---|
Open | - |
Bid | 12.30 |
Ask | 14.50 |
Day's Range | N/A - N/A |
52 Week Range | 9.972 - 25.29 |
Volume | 467 |
Market Cap | 1.04B |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,476,302 |
News & Press Releases

As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · February 12, 2025

Via Benzinga · February 12, 2025

Via Benzinga · November 7, 2024

Via Benzinga · February 4, 2025

The DOE awarded billion-dollar loan guarantees to Calumet and Gevo to boost SAF production and reduce aviation emissions.
Via MarketBeat · October 21, 2024

Via Benzinga · October 17, 2024

Shares of Calumet and Gevo are on the move in extended trading Wednesday after the companies received conditional commitments from the U.S. Department of Energy (DOE).
Via Benzinga · October 16, 2024

Via Benzinga · August 22, 2024

CLMT stock results show that Calumet Specialty Prods beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 9, 2024

These hydrogen stock picks are boasting improving financials that even Wall Street can't deny. Check them out now!
Via InvestorPlace · July 17, 2024

Oil prices surge on anticipation of increased demand and ongoing supply constraints. Goldman Sachs projects continued demand growth until 2034.
Via Benzinga · May 28, 2024

CLMT stock results show that Calumet Specialty Prods beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 10, 2024

CLMT reports Q1 fiscal 2024 sales decline of 3%, beating consensus. Net loss per unit $(0.51) down from $0.23 YoY. Gross profit down 18.7% YoY.
Via Benzinga · May 10, 2024

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Calumet Specialty Products Partners, L.P. (“Calumet” or the “Company”) (NASDAQCLMT) on behalf of Calumet stockholders. Our investigation concerns whether Calumet has violated the federal securities laws and/or engaged in other unlawful business practices.
By Bragar Eagel & Squire · Via GlobeNewswire · February 29, 2024

The law firm of Kirby McInerney LLP is investigating potential claims against Calumet Specialty Products Partners, L.P. (“Calumet” or the “Company”) (NASDAQCLMT). The investigation concerns whether Calumet and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
By Kirby McInerney LLP · Via Business Wire · February 29, 2024

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Calumet Specialty Products Partners, L.P. (“Calumet” or the “Company”) (NASDAQCLMT) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay & Murray LLP · Via Business Wire · February 29, 2024

Law Offices of Howard G. Smith announces an investigation on behalf of Calumet Specialty Products Partners, L.P. (“Calumet” or the “Company”) (NASDAQCLMT) investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Howard G. Smith · Via Business Wire · February 28, 2024

The Law Offices of Frank R. Cruz announces an investigation of Calumet Specialty Products Partners, L.P. (“Calumet” or the “Company”) (NASDAQCLMT) on behalf of investors concerning the Company’s possible violations of federal securities laws.
By The Law Offices of Frank R. Cruz · Via Business Wire · February 28, 2024

Calumet reported Q4 sales decline of 2.3%, beating consensus. Gross profit down 38.3%. Plans to convert to C-Corp by 2024. Montana Renewables returned to normal operations in December.
Via Benzinga · February 23, 2024

Companies Reporting Before The Bell • Fomento Economico (NYSEFMX) is likely to report quarterly earnings at $1.61 per share on revenue of $11.66 billion.
Via Benzinga · February 23, 2024

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Wednesday. Shares of HP Inc. (NYSEHPQ) gained during Wednesday’s session following quarterly results.
Via Benzinga · November 22, 2023

Calumet Specialty Products Partners LP (NASDAQCLMT) reported a third-quarter FY23 sales decline of 1.3% year-over-year to $1.15 billion, beating the cons
Via Benzinga · November 9, 2023

Gainers Intelligent Bio Solutions Inc. (NASDAQINBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
Via Benzinga · November 9, 2023